{
  "docId": "019de072-118b-7459-8ccb-22724833fcd4",
  "docSlug": "04de07fbea9eadeda44cc99f91069101",
  "documentTitle": "AbCellera | Results Presentation Deck | 21 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 21,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "other",
  "function": "summarize",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide uses a grid-like layout to display partner logos and deal details (multi-target/multi-year vs single target, and therapeutic focus).",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/5",
  "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4",
  "deckJsonHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4.json",
  "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.9,
        "w": 0.5,
        "x": 0.45,
        "y": 0.05
      },
      "kind": "image",
      "text": "Partner logos including Moderna, Gilead, Angios, Everest Medicines, Tachyon, EQRx, Empirico",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "617579b3-6e76-4351-8248-36d46b034ab3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.08,
        "y": 0.25
      },
      "kind": "title",
      "text": "PORTFOLIO DIVERSIFIED ACROSS MODALITIES, PARTNER SIZE, DEAL TYPE.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c368ae09-0e56-4145-a898-b7b06fed881b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "a76c8564-6a45-42ee-b226-2a06f1cb9e24",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The company highlights its proven technology leader position in antibody discovery and its diversified portfolio.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 13,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "c116a9b9-66b9-474f-8411-60fed0150046",
      "evidence": "The presentation explains the company's technology and its applications.",
      "position": 0,
      "objective": "Why AbCellera's technology is important for antibody discovery",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}